

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.09346610 |
| 2 | cytidine metabolic process (GO:0046087) | 7.08879214 |
| 3 | cytidine catabolic process (GO:0006216) | 7.08879214 |
| 4 | cytidine deamination (GO:0009972) | 7.08879214 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.24863948 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.95898497 |
| 7 | ubiquinone biosynthetic process (GO:0006744) | 5.20707558 |
| 8 | protein neddylation (GO:0045116) | 5.03125935 |
| 9 | proteasome assembly (GO:0043248) | 5.01266745 |
| 10 | positive regulation of tolerance induction (GO:0002645) | 4.79737956 |
| 11 | regulation of chronic inflammatory response (GO:0002676) | 4.78920733 |
| 12 | ubiquinone metabolic process (GO:0006743) | 4.67957274 |
| 13 | positive T cell selection (GO:0043368) | 4.57025122 |
| 14 | regulation of T cell tolerance induction (GO:0002664) | 4.40336427 |
| 15 | regulation of transmission of nerve impulse (GO:0051969) | 4.40136861 |
| 16 | quinone biosynthetic process (GO:1901663) | 4.26453040 |
| 17 | negative regulation by host of viral transcription (GO:0043922) | 4.08017159 |
| 18 | rRNA modification (GO:0000154) | 3.99194711 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 3.87936010 |
| 20 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.87936010 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.79509492 |
| 22 | ovulation cycle (GO:0042698) | 3.72337877 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71311390 |
| 24 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.68254258 |
| 25 | regulation of tolerance induction (GO:0002643) | 3.67193719 |
| 26 | regulation of female gonad development (GO:2000194) | 3.59728944 |
| 27 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.54813027 |
| 28 | arginine catabolic process (GO:0006527) | 3.51435562 |
| 29 | negative T cell selection (GO:0043383) | 3.49405306 |
| 30 | regulation of bile acid biosynthetic process (GO:0070857) | 3.47188485 |
| 31 | negative regulation of telomere maintenance (GO:0032205) | 3.45576682 |
| 32 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.43475322 |
| 33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.43475322 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.42757889 |
| 35 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.41512965 |
| 36 | respiratory chain complex IV assembly (GO:0008535) | 3.41068695 |
| 37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.40832405 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.40832405 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.40832405 |
| 40 | meiotic chromosome segregation (GO:0045132) | 3.38816219 |
| 41 | actin nucleation (GO:0045010) | 3.36798955 |
| 42 | maturation of 5.8S rRNA (GO:0000460) | 3.36736752 |
| 43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.35447448 |
| 44 | response to pheromone (GO:0019236) | 3.33585844 |
| 45 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.31807184 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.30767330 |
| 47 | rRNA methylation (GO:0031167) | 3.29854751 |
| 48 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.29337886 |
| 49 | mismatch repair (GO:0006298) | 3.28968782 |
| 50 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25833553 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.25109962 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.25109962 |
| 53 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.24590616 |
| 54 | arginine metabolic process (GO:0006525) | 3.22110704 |
| 55 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.19096113 |
| 56 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.19096113 |
| 57 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.14127292 |
| 58 | pseudouridine synthesis (GO:0001522) | 3.11761441 |
| 59 | positive regulation of humoral immune response (GO:0002922) | 3.10935953 |
| 60 | base-excision repair, AP site formation (GO:0006285) | 3.07467161 |
| 61 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.06831667 |
| 62 | respiratory electron transport chain (GO:0022904) | 3.01857933 |
| 63 | electron transport chain (GO:0022900) | 3.01757686 |
| 64 | glycerol metabolic process (GO:0006071) | 3.00222395 |
| 65 | negative regulation of viral genome replication (GO:0045071) | 3.00092202 |
| 66 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.98352206 |
| 67 | positive regulation of fatty acid oxidation (GO:0046321) | 2.98164840 |
| 68 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.97364905 |
| 69 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.97364905 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96583652 |
| 71 | alkaloid metabolic process (GO:0009820) | 2.94105745 |
| 72 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.92196531 |
| 73 | positive regulation of cell cycle arrest (GO:0071158) | 2.90239332 |
| 74 | regulation of cellular amine metabolic process (GO:0033238) | 2.88701506 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.88500072 |
| 76 | positive regulation of prostaglandin secretion (GO:0032308) | 2.88382363 |
| 77 | modulation by host of symbiont transcription (GO:0052472) | 2.84384345 |
| 78 | modulation by host of viral transcription (GO:0043921) | 2.84384345 |
| 79 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.84334936 |
| 80 | thymic T cell selection (GO:0045061) | 2.82065166 |
| 81 | alditol metabolic process (GO:0019400) | 2.81028940 |
| 82 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.80358057 |
| 83 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.79077381 |
| 84 | cytochrome complex assembly (GO:0017004) | 2.78270411 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.76729884 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75314157 |
| 87 | T cell selection (GO:0045058) | 2.71851707 |
| 88 | negative regulation of neurological system process (GO:0031645) | 2.70074796 |
| 89 | regulation of viral genome replication (GO:0045069) | 2.69089652 |
| 90 | response to interferon-beta (GO:0035456) | 2.69023457 |
| 91 | behavioral response to nicotine (GO:0035095) | 2.68039883 |
| 92 | protein complex biogenesis (GO:0070271) | 2.67935092 |
| 93 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.67770044 |
| 94 | cytokine biosynthetic process (GO:0042089) | 2.64544905 |
| 95 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64403376 |
| 96 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.63850271 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.63518147 |
| 98 | cellular response to interferon-beta (GO:0035458) | 2.62377173 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.60175471 |
| 100 | response to xenobiotic stimulus (GO:0009410) | 2.59200629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.45887443 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69772235 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.20746985 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.10541836 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.10147360 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05866109 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.95014292 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69532070 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.59257698 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53147622 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.47412520 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44666914 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.43507771 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39385114 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.26692393 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15359609 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86736925 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73182160 |
| 19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71796096 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70266153 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.68984537 |
| 22 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.65728601 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63933171 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63316542 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60412061 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57179213 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.56321960 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56312969 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53064276 |
| 30 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.46380098 |
| 31 | NCOR_22424771_ChIP-Seq_293T_Human | 1.46194250 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.45241759 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44208168 |
| 34 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.42770264 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40839707 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39796788 |
| 37 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37873705 |
| 38 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.36825917 |
| 39 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35911208 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35154260 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34740674 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.33634263 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33498937 |
| 44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31621778 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30135262 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.28902390 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27599299 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27599299 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26835764 |
| 50 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26552815 |
| 51 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.25774638 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25521802 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25213836 |
| 54 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23243834 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22881380 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.22841985 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21575934 |
| 58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21453345 |
| 59 | GATA3_26560356_Chip-Seq_TH1_Human | 1.20994940 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18615940 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18615940 |
| 62 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.18478573 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17547670 |
| 64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.17026069 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16404776 |
| 66 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.16115902 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.15752842 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14288959 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13565370 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.12670245 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12018818 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11669338 |
| 73 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11502337 |
| 74 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10454481 |
| 75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08446122 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.08253856 |
| 77 | ERA_21632823_ChIP-Seq_H3396_Human | 1.07931507 |
| 78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05390610 |
| 79 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99191664 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98108026 |
| 81 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97634956 |
| 82 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.96065897 |
| 83 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95838258 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95427821 |
| 85 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94599218 |
| 86 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94146721 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93991971 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93841547 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93794826 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93021886 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92832947 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92604134 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91828810 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91700628 |
| 95 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91184360 |
| 96 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89246918 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88659010 |
| 98 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88659010 |
| 99 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88317355 |
| 100 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88126628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 5.81617283 |
| 2 | MP0005646_abnormal_pituitary_gland | 3.41901651 |
| 3 | MP0005360_urolithiasis | 2.59351468 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.56998121 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.44577605 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.37305380 |
| 7 | MP0001873_stomach_inflammation | 2.31533161 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.28554335 |
| 9 | MP0000685_abnormal_immune_system | 2.27790481 |
| 10 | MP0005671_abnormal_response_to | 2.24996068 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.11050583 |
| 12 | MP0005187_abnormal_penis_morphology | 2.03316853 |
| 13 | MP0009764_decreased_sensitivity_to | 2.03114297 |
| 14 | MP0009785_altered_susceptibility_to | 2.01879793 |
| 15 | MP0003195_calcinosis | 2.01074355 |
| 16 | MP0009697_abnormal_copulation | 2.00961109 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 1.98313998 |
| 18 | MP0001188_hyperpigmentation | 1.97607398 |
| 19 | MP0006082_CNS_inflammation | 1.95630755 |
| 20 | MP0005083_abnormal_biliary_tract | 1.94388249 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90962754 |
| 22 | MP0008007_abnormal_cellular_replicative | 1.79141607 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.78960878 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.78433238 |
| 25 | MP0001790_abnormal_immune_system | 1.76200264 |
| 26 | MP0005387_immune_system_phenotype | 1.76200264 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.73384381 |
| 28 | MP0001984_abnormal_olfaction | 1.73161856 |
| 29 | MP0003186_abnormal_redox_activity | 1.72335018 |
| 30 | MP0003315_abnormal_perineum_morphology | 1.68099831 |
| 31 | MP0000613_abnormal_salivary_gland | 1.64150978 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.58720886 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.58405027 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.56777393 |
| 35 | MP0002736_abnormal_nociception_after | 1.54334462 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.51566388 |
| 37 | MP0008872_abnormal_physiological_respon | 1.49260788 |
| 38 | MP0003646_muscle_fatigue | 1.47493315 |
| 39 | MP0003123_paternal_imprinting | 1.47157247 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.46393860 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.43153005 |
| 42 | MP0003252_abnormal_bile_duct | 1.42454489 |
| 43 | MP0001800_abnormal_humoral_immune | 1.42141206 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.38501519 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.29965775 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.29303941 |
| 47 | MP0004043_abnormal_pH_regulation | 1.26327519 |
| 48 | MP0001727_abnormal_embryo_implantation | 1.23741070 |
| 49 | MP0002006_tumorigenesis | 1.19175453 |
| 50 | MP0003075_altered_response_to | 1.17543355 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.16131345 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15806139 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.13620983 |
| 54 | MP0006054_spinal_hemorrhage | 1.13100906 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.11961384 |
| 56 | MP0002723_abnormal_immune_serum | 1.09798471 |
| 57 | MP0005165_increased_susceptibility_to | 1.07649755 |
| 58 | MP0002272_abnormal_nervous_system | 1.07484656 |
| 59 | MP0005389_reproductive_system_phenotype | 1.07312948 |
| 60 | MP0001819_abnormal_immune_cell | 1.06972330 |
| 61 | MP0001905_abnormal_dopamine_level | 1.06086364 |
| 62 | MP0002139_abnormal_hepatobiliary_system | 1.05478479 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.97564374 |
| 64 | MP0005025_abnormal_response_to | 0.95715552 |
| 65 | MP0001919_abnormal_reproductive_system | 0.94056623 |
| 66 | MP0009745_abnormal_behavioral_response | 0.93780604 |
| 67 | MP0000716_abnormal_immune_system | 0.93640182 |
| 68 | MP0002452_abnormal_antigen_presenting | 0.91556747 |
| 69 | MP0002733_abnormal_thermal_nociception | 0.90523147 |
| 70 | MP0010155_abnormal_intestine_physiology | 0.90288138 |
| 71 | MP0001845_abnormal_inflammatory_respons | 0.87802743 |
| 72 | MP0003786_premature_aging | 0.86620585 |
| 73 | MP0002160_abnormal_reproductive_system | 0.85813576 |
| 74 | MP0005365_abnormal_bile_salt | 0.84777819 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 0.83112872 |
| 76 | MP0003718_maternal_effect | 0.83036237 |
| 77 | MP0006276_abnormal_autonomic_nervous | 0.82373227 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.81670844 |
| 79 | MP0002405_respiratory_system_inflammati | 0.80964960 |
| 80 | MP0008873_increased_physiological_sensi | 0.80925412 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.80526807 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.80086395 |
| 83 | MP0004084_abnormal_cardiac_muscle | 0.79922989 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.78854562 |
| 85 | MP0009046_muscle_twitch | 0.78415414 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.78025425 |
| 87 | MP0002398_abnormal_bone_marrow | 0.77881948 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 0.77210236 |
| 89 | MP0000516_abnormal_urinary_system | 0.77210236 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.76836576 |
| 91 | MP0005253_abnormal_eye_physiology | 0.75531332 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.75119189 |
| 93 | MP0001243_abnormal_dermal_layer | 0.73283383 |
| 94 | MP0008469_abnormal_protein_level | 0.72987435 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.72148655 |
| 96 | MP0003868_abnormal_feces_composition | 0.71769738 |
| 97 | MP0005535_abnormal_body_temperature | 0.70890375 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.70381330 |
| 99 | MP0002102_abnormal_ear_morphology | 0.70013762 |
| 100 | MP0002722_abnormal_immune_system | 0.68228526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.56597526 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.28127890 |
| 3 | Autoimmune hemolytic anemia (HP:0001890) | 4.05065866 |
| 4 | Increased IgM level (HP:0003496) | 4.04842967 |
| 5 | Acute encephalopathy (HP:0006846) | 3.93083951 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.92212137 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.89633250 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.81350530 |
| 9 | Increased CSF lactate (HP:0002490) | 3.73947319 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.73913457 |
| 11 | Prostate neoplasm (HP:0100787) | 3.69846389 |
| 12 | Large eyes (HP:0001090) | 3.45224501 |
| 13 | Abnormality of the prostate (HP:0008775) | 3.42037191 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.36470704 |
| 15 | Decreased central vision (HP:0007663) | 3.16139573 |
| 16 | Eosinophilia (HP:0001880) | 3.09018652 |
| 17 | Congenital, generalized hypertrichosis (HP:0004540) | 3.05593820 |
| 18 | Cerebral edema (HP:0002181) | 3.01686713 |
| 19 | Fair hair (HP:0002286) | 2.96245169 |
| 20 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.92865484 |
| 21 | Abnormality of alanine metabolism (HP:0010916) | 2.92865484 |
| 22 | Hyperalaninemia (HP:0003348) | 2.92865484 |
| 23 | Renal cortical cysts (HP:0000803) | 2.84993863 |
| 24 | Hepatic necrosis (HP:0002605) | 2.80480915 |
| 25 | Submucous cleft hard palate (HP:0000176) | 2.79918241 |
| 26 | Pancytopenia (HP:0001876) | 2.75003504 |
| 27 | Optic disc pallor (HP:0000543) | 2.72166494 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.71176422 |
| 29 | Pancreatic cysts (HP:0001737) | 2.70145278 |
| 30 | Abnormality of eosinophils (HP:0001879) | 2.62444296 |
| 31 | Chronic sinusitis (HP:0011109) | 2.62303025 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.60549721 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.59753132 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 2.50411353 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.45989145 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 2.44010757 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.43963349 |
| 38 | Aplastic anemia (HP:0001915) | 2.43160356 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.42823090 |
| 40 | Generalized hypopigmentation of hair (HP:0011358) | 2.36933368 |
| 41 | Alveolar cell carcinoma (HP:0006519) | 2.36458876 |
| 42 | Dry hair (HP:0011359) | 2.36405020 |
| 43 | Hypokinesia (HP:0002375) | 2.34591254 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.34364612 |
| 45 | Stomatitis (HP:0010280) | 2.34013026 |
| 46 | Ridged nail (HP:0001807) | 2.33980850 |
| 47 | Granulocytopenia (HP:0001913) | 2.27186226 |
| 48 | Respiratory failure (HP:0002878) | 2.22652960 |
| 49 | Ulnar claw (HP:0001178) | 2.22021209 |
| 50 | Hypoproteinemia (HP:0003075) | 2.21638159 |
| 51 | Lactic acidosis (HP:0003128) | 2.20904422 |
| 52 | Microretrognathia (HP:0000308) | 2.18565947 |
| 53 | Abnormality of the vocal cords (HP:0008777) | 2.17878674 |
| 54 | True hermaphroditism (HP:0010459) | 2.15820324 |
| 55 | IgG deficiency (HP:0004315) | 2.15275671 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.13467261 |
| 57 | Oral leukoplakia (HP:0002745) | 2.12576954 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.06143735 |
| 59 | Lethargy (HP:0001254) | 2.05594255 |
| 60 | Abnormality of the axillary hair (HP:0100134) | 2.03778001 |
| 61 | Abnormality of secondary sexual hair (HP:0009888) | 2.03778001 |
| 62 | Increased serum lactate (HP:0002151) | 2.02828672 |
| 63 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01679583 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.00977304 |
| 65 | Parakeratosis (HP:0001036) | 1.99388832 |
| 66 | Leukocytosis (HP:0001974) | 1.97864218 |
| 67 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.95024144 |
| 68 | Gangrene (HP:0100758) | 1.94424132 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94403303 |
| 70 | Clubbing of toes (HP:0100760) | 1.94094674 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 1.93956192 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 1.93142419 |
| 73 | Erythema (HP:0010783) | 1.91249123 |
| 74 | Thyroiditis (HP:0100646) | 1.87801720 |
| 75 | Vasculitis (HP:0002633) | 1.87738087 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 1.85896610 |
| 77 | Bile duct proliferation (HP:0001408) | 1.85896610 |
| 78 | Respiratory difficulties (HP:0002880) | 1.85419610 |
| 79 | Nephronophthisis (HP:0000090) | 1.85096434 |
| 80 | Keratoconus (HP:0000563) | 1.83978762 |
| 81 | Increased corneal curvature (HP:0100692) | 1.83978762 |
| 82 | Congenital hepatic fibrosis (HP:0002612) | 1.83320766 |
| 83 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.82243055 |
| 84 | Combined immunodeficiency (HP:0005387) | 1.80945542 |
| 85 | Abnormality of male internal genitalia (HP:0000022) | 1.80047243 |
| 86 | Abnormality of B cell number (HP:0010975) | 1.79662374 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77877482 |
| 88 | Leukodystrophy (HP:0002415) | 1.77395428 |
| 89 | Sclerocornea (HP:0000647) | 1.76554954 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 1.76221721 |
| 91 | Delayed CNS myelination (HP:0002188) | 1.76135262 |
| 92 | Pancreatic fibrosis (HP:0100732) | 1.73136020 |
| 93 | Bilateral microphthalmos (HP:0007633) | 1.72769916 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.71655369 |
| 95 | Pulmonary infiltrates (HP:0002113) | 1.69854337 |
| 96 | Scanning speech (HP:0002168) | 1.68960554 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 1.68864584 |
| 98 | Mesangial abnormality (HP:0001966) | 1.66462584 |
| 99 | Bronchitis (HP:0012387) | 1.65167168 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65009892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.21856399 |
| 2 | SRPK1 | 3.37720440 |
| 3 | BUB1 | 3.33423124 |
| 4 | MAP4K1 | 3.07047750 |
| 5 | VRK2 | 2.92846908 |
| 6 | TXK | 2.68782309 |
| 7 | WNK4 | 2.60081181 |
| 8 | PIK3CA | 2.44912016 |
| 9 | ADRBK2 | 2.36470400 |
| 10 | PDK2 | 2.31861618 |
| 11 | AKT3 | 2.30531959 |
| 12 | BCKDK | 2.25285251 |
| 13 | VRK1 | 2.18380425 |
| 14 | EIF2AK3 | 2.07890756 |
| 15 | NUAK1 | 1.69435175 |
| 16 | NEK1 | 1.67388625 |
| 17 | PHKG2 | 1.63405927 |
| 18 | PHKG1 | 1.63405927 |
| 19 | GRK1 | 1.62439976 |
| 20 | PLK2 | 1.58460129 |
| 21 | PRKCQ | 1.55902509 |
| 22 | FRK | 1.55245296 |
| 23 | CLK1 | 1.51464278 |
| 24 | TLK1 | 1.41248035 |
| 25 | ITK | 1.34968735 |
| 26 | IKBKB | 1.34815760 |
| 27 | STK4 | 1.22563507 |
| 28 | WNK3 | 1.18140303 |
| 29 | TESK2 | 1.13929764 |
| 30 | TIE1 | 1.06987970 |
| 31 | PLK3 | 1.05240396 |
| 32 | EIF2AK1 | 1.04713745 |
| 33 | LYN | 1.04539003 |
| 34 | SYK | 1.00728884 |
| 35 | PIM2 | 1.00526204 |
| 36 | INSRR | 0.99665198 |
| 37 | CSF1R | 0.98581739 |
| 38 | MAP3K11 | 0.97189595 |
| 39 | TRIM28 | 0.94167197 |
| 40 | PRKCH | 0.93714363 |
| 41 | TAF1 | 0.93442936 |
| 42 | MAPKAPK3 | 0.92406627 |
| 43 | PRKCG | 0.91581667 |
| 44 | PTK6 | 0.89434579 |
| 45 | ZAK | 0.86329168 |
| 46 | MAP3K12 | 0.86035324 |
| 47 | LCK | 0.81670817 |
| 48 | PTK2B | 0.80829532 |
| 49 | DAPK1 | 0.78284756 |
| 50 | AURKA | 0.74387550 |
| 51 | BRAF | 0.74372802 |
| 52 | OXSR1 | 0.72745426 |
| 53 | EIF2AK2 | 0.72463984 |
| 54 | TSSK6 | 0.71557372 |
| 55 | PRKCE | 0.71280807 |
| 56 | PAK2 | 0.70714029 |
| 57 | CAMKK2 | 0.69026742 |
| 58 | IKBKE | 0.67469519 |
| 59 | NME1 | 0.67110638 |
| 60 | MYLK | 0.66080919 |
| 61 | CSNK1G3 | 0.63617676 |
| 62 | TBK1 | 0.63536547 |
| 63 | MAPKAPK5 | 0.62015227 |
| 64 | FES | 0.60853807 |
| 65 | ZAP70 | 0.60367933 |
| 66 | GRK5 | 0.59731095 |
| 67 | PRKCI | 0.58901313 |
| 68 | CSNK1G1 | 0.58469517 |
| 69 | LIMK1 | 0.58278522 |
| 70 | PRKACA | 0.56654321 |
| 71 | CSNK1A1L | 0.56364388 |
| 72 | EPHB2 | 0.55938800 |
| 73 | PRKCA | 0.54587430 |
| 74 | DYRK2 | 0.52968456 |
| 75 | STK39 | 0.52656004 |
| 76 | PRKCZ | 0.52377656 |
| 77 | PINK1 | 0.51708751 |
| 78 | CSNK1G2 | 0.49941224 |
| 79 | MAPK13 | 0.49937979 |
| 80 | MAP2K7 | 0.49101010 |
| 81 | CSNK2A2 | 0.48917315 |
| 82 | PLK1 | 0.48205087 |
| 83 | BMPR1B | 0.48153030 |
| 84 | CSNK1A1 | 0.45270467 |
| 85 | CSK | 0.44653292 |
| 86 | MINK1 | 0.44317390 |
| 87 | KIT | 0.43616454 |
| 88 | CSNK1D | 0.42955493 |
| 89 | CDC7 | 0.42415763 |
| 90 | TNIK | 0.41433189 |
| 91 | OBSCN | 0.41219818 |
| 92 | TTK | 0.40811827 |
| 93 | IGF1R | 0.39277059 |
| 94 | MUSK | 0.38773043 |
| 95 | PRKACG | 0.38722921 |
| 96 | PRKG1 | 0.38175032 |
| 97 | MARK3 | 0.37346846 |
| 98 | PRKCD | 0.37068844 |
| 99 | INSR | 0.35786982 |
| 100 | CSNK2A1 | 0.34524953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.94916869 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.93121742 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.06075507 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04366029 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.93064074 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.88244844 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84452543 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79868739 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.73948614 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.40457553 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02413818 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83245989 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.78455969 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65796698 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62204923 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.58308017 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56690760 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56405348 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44464835 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43087136 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42404191 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.42214946 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.40663758 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40598981 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37921491 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.32125606 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.28754796 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20325463 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18803606 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12838759 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09464286 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07164166 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.06793766 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06319595 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05657344 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00149070 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98944453 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97220252 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97147931 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96925127 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94074995 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.90980734 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89105551 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 0.88054672 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87477108 |
| 46 | RNA polymerase_Homo sapiens_hsa03020 | 0.84656104 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84128925 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81920005 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80242073 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80108880 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77747380 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77201008 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75947533 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75832843 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73970041 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.68538082 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67585939 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.66950317 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.66325293 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65436771 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64882554 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64867554 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64633342 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63014701 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.62592339 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62562429 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62377996 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59308164 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57730161 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57304459 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57258289 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56966539 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55472255 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51335250 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50337090 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49521918 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47717983 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.47536402 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.47358302 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46607553 |
| 81 | Base excision repair_Homo sapiens_hsa03410 | 0.46003537 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45011506 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.44911800 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44821049 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43284448 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43075529 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43062020 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42591138 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.40541619 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37673378 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34842494 |
| 92 | Mismatch repair_Homo sapiens_hsa03430 | 0.32872640 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32710199 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28590217 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27482789 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27463223 |
| 97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.23795024 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23187792 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.23098129 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22771208 |

